NCT01405950View on ClinicalTrials.gov

Phase 1b Study of Tizanidine in Pediatric Patients With Cerebral Palsy

PHASE1TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Spasticity Due to Cerebral Palsy
Interventions
DRUG

Zanaflex Capsules

0.025 mg/kg

DRUG

Zanaflex Capsules

0.05 mg/kg

DRUG

Zanaflex Capsules

0.075 mg/kg

DRUG

Zanaflex Capsules

0.1 mg/kg

Trial Locations (1)

40202

University of Louisville Department of Neurology dba Kentucky Neuroscience Research Health Care Outpatient Center (HCOC), Louisville

Sponsors

Collaborators (1)

Syneos Health
All Listed Sponsors
collaborator

Syneos Health

OTHER

lead

Acorda Therapeutics

INDUSTRY